| Nov 12 |
Lifecore Biomedical to Present at Stephens Annual Investment Conference
|
| Nov 12 |
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge funds
|
| Nov 12 |
Lifecore Biomedical: Finally A 'Pure Play' CDMO Business
|
| Nov 4 |
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
|
| Oct 11 |
Lifecore Biomedical GAAP EPS of -$0.53, revenue of $24.7M
|
| Oct 7 |
Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ...
|
| Oct 4 |
Lifecore Biomedical, Inc. (LFCR) Q1 2025 Earnings Call Transcript
|
| Oct 4 |
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
|
| Oct 4 |
Lifecore Biomedical raises $24.3M through private placement
|
| Oct 4 |
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
|
